Xilio Therapeutics
34 hedge funds and large institutions have $9.1M invested in Xilio Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
73% less capital invested
Capital invested by funds: $33.5M → $9.1M (-$24.4M)
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$126K | |
| 2 | +$104K | |
| 3 | +$45.9K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$28.3K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$24.8K |
Top Sellers
| 1 | -$878K | |
| 2 | -$479K | |
| 3 | -$293K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$124K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$55.8K |